Ligand Pharmaceuticals
LGND
LGND
261 hedge funds and large institutions have $2.47B invested in Ligand Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 115 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
31% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 115
72% less call options, than puts
Call options by funds: $39.1M | Put options by funds: $139M
Holders
261
Holding in Top 10
5
Calls
$39.1M
Puts
$139M
Top Buyers
| 1 | +$31.5M | |
| 2 | +$30.1M | |
| 3 | +$24.3M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$18.5M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$14.8M |
Top Sellers
| 1 | -$51.9M | |
| 2 | -$35.3M | |
| 3 | -$27.1M | |
| 4 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$17.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14.6M |